Dopaminergic medication improves cognitive control under low cognitive demand in Parkinson’s disease.

Dopaminergic medication improves cognitive control under low cognitive demand in Parkinson’s disease.

Publication date: Mar 23, 2020

Dopamine agonists are the main pharmacological intervention for the motor symptoms of Parkinson’s disease (PD). However, dopaminergic medication has been associated with disinhibitory psychopathology in some patients. The aim of this study was to test the effect of dopaminergic medication on inhibitory control in patients with PD using the paced Random Number Generation task (RNG), which requires inhibition of prepotent counting in series to produce a random sequence of numbers.

Twenty-three PD patients performed RNG on and off dopaminergic medication. Cognitive load was manipulated by performing RNG at faster (1Hz) and slower (0.5 Hz) rates. For RNG, two scores (CS1 and CS2) were derived, which are considered indices of more automatic and more controlled counting, respectively.

There were no main effects of medication on RNG performance. There was a significant main effect of cognitive load on CS1, with higher CS1 scores at the faster rate (p =

Williams, I.A., , Obeso, and Jahanshahi, M. Dopaminergic medication improves cognitive control under low cognitive demand in Parkinson’s disease. 24444. 2020 Neuropsychology.

Concepts Keywords
Cognitive Drugs
Cognitive Control Branches of biology
Cognitive Load Organ systems
Dopamine Catecholamines
Dopaminergic Dopamine
Hz Neurotransmitters
Inhibitory Control Phenethylamines
Neuropsychology
Parkinson
Pharmacological
Psychopathology
Random Sequence

Semantics

Type Source Name
drug DRUGBANK Dopamine

Original Article

Leave a Comment

Your email address will not be published. Required fields are marked *